|Articles|December 1, 1995

November/December 1995
Volume 1
Issue 3

Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Author(s)Ira J. Goodman, MD

Download PDF: Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Articles in this issue

over 30 years ago

Article

Life-Effectiveness Analysis: A Technique for Trading Clinical Life-Years for Societal Life-Years

over 30 years ago

Article

Proton Pump Inhibitors Versus H2-Receptor Antagonists for the Treatment of Erosive Gastroesophageal Reflux Disease: A Cost-Comparative Study

over 30 years ago

Article

Antihypertensive Therapy: Factors Affecting Medication Compliance and Blood Pressure Control

over 30 years ago

Article

Appropriate Use of Abdominal Ultrasonography in Two Hospitals

over 30 years ago

Article

Long-Term Management of Gastroesophageal Reflux Disease

over 30 years ago

Article

Life-Effectiveness Analysis -- More Shadow Than Light?

over 30 years ago

Article

The Role of the AHCPR in Clinical Guidelines Development

over 30 years ago

Article

Modeling Member Satisfaction in the Management of Pediatric Nocturnal Enuresis

over 30 years ago

Article

The Opportunities for Educational Interventions in the Psychosocial and Behavioral Barriers to Asthma Management

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care